In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?"

J Am Acad Dermatol. 2011 Apr;64(4):788-90. doi: 10.1016/j.jaad.2010.10.033.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cyclosporine / therapeutic use*
  • Dermatologic Agents / therapeutic use*
  • Evidence-Based Medicine
  • Hepatitis C, Chronic / epidemiology*
  • Humans
  • Psoriasis / drug therapy*
  • Psoriasis / epidemiology*
  • Risk Factors

Substances

  • Dermatologic Agents
  • Cyclosporine